{"public_id":"cl_78279498d0ef915a747e809078644ff4","status":"active","superseded_by_public_id":null,"corpus_id":25847740,"text":"In mice with experimental meningoencephalitis due to Naegleria fowleri, survival over 1 month was 25% with roxithromycin treatment and 80% with rokitamycin treatment, with mean times to death of 16.2 and 16.8 days respectively compared with 11.2 days for control mice.","confidence":0.9,"paper":{"corpus_id":25847740,"title":"Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.","url":"https://sah.borca.ai/papers/25847740"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":1},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0f8f9c77ba9ce84b26a28aec55866b6b","name":"roxithromycin","description":"A macrolide antibacterial agent tested here for amoebicidal activity against N. fowleri, evaluated in vitro and in a mouse infection model.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_0f8f9c77ba9ce84b26a28aec55866b6b"},{"public_id":"co_6152caf8c53b5d17458307e85e939e2c","name":"rokitamycin","description":"A macrolide antibacterial agent tested here for amoebicidal activity against N. fowleri, evaluated in vitro and in a mouse infection model.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_6152caf8c53b5d17458307e85e939e2c"},{"public_id":"co_617813889daebcc070760f39bf5ac10a","name":"experimental meningoencephalitis","description":"A mouse model of N. fowleri infection used to test the in vivo therapeutic efficacy of candidate drugs.","types":["animal model"],"url":"https://sah.borca.ai/concepts/co_617813889daebcc070760f39bf5ac10a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_78279498d0ef915a747e809078644ff4"}